Overexpression of human epidermal growth factor receptor-2 (HER2) in GC activates Wnt/β-catenin pathway in GCSCs, leading to enhanced invasiveness and treatment resistance of gastric cancer cells (69). Here, ERBB2 is linked to gastric cancer.